merck &amp co new hiv drug is approved by fda for some patients the food and drug administration approved a new type of hiv drug from merck &amp co of whitehouse station n j the drug known by the brand name isentress was approved for use in patients who have failed treatment with other hiv drugs and who have hiv resistant to multiple drugs isentress was approved as part of the fdas accelerated approval mechanism which is aimed at getting life saving treatments to market faster by allowing companies to submit less clinical data companies obtaining accelerated approval must keep studying drugs to gain full approval isentress is designed to target one of three enzymes needed by hiv to reproduce current drugs on the market attack the other two enzymes reverse transcriptase and protease isentress will be the only drug to target the third enzyme known as integrase 
